LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Aldrovandi, MacEler
Languages: English
Types: Doctoral thesis
Subjects: QR180, R1

Classified by OpenAIRE into

mesheuropmc: lipids (amino acids, peptides, and proteins)
Initially, prostaglandins (PGs) were considered to only exist as free acid mediators. Although, formation of PG glycerol esters and PG ethanolamides by cellular cyclooxygenase (COX)-2 has been reported, generation of complex oxidised lipids via COX-1 has not been considered. In this study, formation of sixteen unique PG-containing phospholipids generated by agonist-activated human platelets is demonstrated using lipidomic approaches. Precursor scanning-tandem mass spectrometry identified a group of specific lipids comprising PGE2, PGD2 and two previously undescribed PG-like molecules (named PGb and PGc), attached to four phosphatidylethanolamine (PE) phospholipids (16:0p/, 18:1p/, 18:0p/ and 18:0a/). PGb and PGc were also detected as free eicosanoids and their structures remain to be characterised. These novel lipids formed within 2-5 minutes of platelet activation by thrombin, collagen or ionophore and required activation of several intracellular signalling intermediates, including cytosolic phospholipase A2 (cPLA2), p38 mitogen-activated protein kinase (MAPK), src tyrosine kinases, phospholipase C (PLC) and cytosolic calcium. Unlike free PGs that are secreted, PG-PEs remain cell associated, suggesting an autocrine mode of action. Aspirin supplementation in vivo (75 mg/day) or in vitro (1 mM) blocked their generation, indicating that COX-1 is required. Pharmacological studies using inhibitors of fatty acyl re-esterification significantly reduced formation of PG-PEs. Furthermore, purified COX-1 was unable to directly oxidise PE in vitro. Collectively, these indicate that PG-PEs are initially formed as free PGs via COX-1, and then rapidly esterified into PEs. In summary, this is the first demonstration of acute generation of PG-PEs in agonist-activated human platelets from endogenous substrate via COX-1. These unique lipids may represent additional bioactive molecules from this key platelet enzyme.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Yeung J & Holinstat M. 12-lipoxygenase: a potential target for novel anti-platelet therapeutics. Cardiovasc Hematol Agents Med Chem. 2011, 9(3):154-64.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article